Accessibility Menu
 
Black Bird Biotech logo

Black Bird Biotech

(OTC) BBBT

Current Price$0.00
Market Cap$3,700
Since IPO (2020)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Black Bird Biotech Financials at a Glance

Market Cap

$3,700

Revenue (TTM)

$36.32K

Net Income (TTM)

$1.02M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-5.89 (Low)

Price

$0.00

Volume

10,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

BBBT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Black Bird Biotech

Industry

Pharmaceuticals

Employees

4

CEO

Nelson W. Grist

Headquarters

Argyle, TX 75028, US

BBBT Financials

Key Financial Metrics (TTM)

Gross Margin

-68%

Operating Margin

-16%

Net Income Margin

-20%

Return on Equity

0%

Return on Capital

2%

Return on Assets

-8%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.70K

Shares Outstanding

3.73B

Volume

10.00K

Avg. Volume

14.84K

Financials (TTM)

Gross Profit

$55.91K

Operating Income

$1.29M

EBITDA

$1.20M

Operating Cash Flow

$1.03M

Capital Expenditure

$4.00

Free Cash Flow

$1.03M

Cash & ST Invst.

$44.45K

Total Debt

$669.77K

Black Bird Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2023YOY CHG

Revenue

$3.94K

-84.7%

Gross Profit

$1.42K

-89.4%

Gross Margin

36.02%

N/A

Market Cap

$3.70K

N/A

Market Cap/Employee

$925.00

N/A

Employees

4

N/A

Net Income

$131.23K

+51.6%

EBITDA

$41.70K

+126.7%

Quarterly Fundamentals

Name
Q3 2023YOY CHG

Net Cash

$742.38K

-26.1%

Accounts Receivable

$1.55K

-60.3%

Inventory

$75.46K

-16.3%

Long Term Debt

$2.88K

N/A

Short Term Debt

$745.23K

+13.8%

Return on Assets

-7.59%

N/A

Return on Invested Capital

1.98%

N/A

Free Cash Flow

$4.90K

+96.1%

Operating Cash Flow

$4.90K

+96.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EAPHParallel Industries Inc.
$0.00+0.00%
ADVTAdvantis Corp.
$0.00+0.00%
PBLAPanbela Therapeutics, Inc.
$0.01+0.00%
NVOSNovo Integrated Sciences, Inc.
$0.00+6.45%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.14-0.01%
CNSPCns Pharmaceuticals
$7.84+2.39%
GBTGGlobal Business Travel Group
$9.34+0.58%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.18+0.01%

Questions About BBBT

What is the current price of Black Bird Biotech?

Black Bird Biotech is trading at N/A per share.

What is the 52-week range for Black Bird Biotech?

Over the past 52 weeks, Black Bird Biotech has traded between N/A and $0.00.

How much debt does Black Bird Biotech have?

As of the most recent reporting period, Black Bird Biotech reported total debt of $669,775.

How much cash does Black Bird Biotech have on hand?

Black Bird Biotech reported $44,448 in cash and cash equivalents in its most recent financial results.

What is Black Bird Biotech’s dividend yield?

Black Bird Biotech does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.